|Bid||0.00 x 900|
|Ask||0.00 x 1400|
|Day's Range||57.92 - 59.28|
|52 Week Range||42.68 - 61.86|
|PE Ratio (TTM)||78.09|
|Earnings Date||Aug 6, 2018 - Aug 10, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.67|
Orthofix International N.V., (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the realignment of its strategic business units and the promotion of Brad Niemann to President of Global Orthofix Spine, which includes the BioStim, Spine Fixation, Spinal Kinetics and Biologics businesses. The Extremity Fixation business, which will now be referred to as “Orthofix Extremities” will continue to be led globally by Davide Bianchi as the President of Global Orthofix Extremities.
I am going to run you through how I calculated the intrinsic value of Orthofix International NV (NASDAQ:OFIX) by projecting its future cash flows and then discounting them to today’sRead More...
Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.
NEW YORK, June 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern ...
Spine stocks were steadied with supportive coverage from the Street this week. The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED ...
Orthofix International N.V. , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2018 Global Healthcare Conference in New York City on Tuesday, June 5, 2018 at 3:30 p.m.
Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.
On a per-share basis, the Willemstad, Netherlands Antilles-based company said it had net income of 27 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came ...
Orthofix International N.V. today reported its financial results for the first quarter ended March 31, 2018. Net sales were $108.7 million, diluted earnings per share from continuing operations was $0.27 and adjusted earnings per share from continuing operations was $0.39.
NEW YORK, NY / ACCESSWIRE / April 30, 2018 / Orthofix International NV (NASDAQ: OFIX ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 30, 2018 at 4:30 PM Eastern ...
Orthofix International N.V. (OFIX), a global medical device company focused on musculoskeletal healing products and value-added services, today announced that it plans to release financial results for the first quarter 2018 after market close on Monday, April 30, 2018. Brad Mason, Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 5288605.
3D printing lends a competitive edge to medical device manufacturers by enhancing efficiency and cutting down on processing time.
Stock Monitor: AcelRx Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 26, 2018 / Active-Investors.com has just released a free research report on Orthofix International N.V. (NASDAQ: OFIX ...
Orthofix International N.V., , a global medical device company focused on musculoskeletal healing products and value added services, announced the U.S. Food and Drug Administration 510 clearance for its new internal fixation system, the G-Beam™ Fusion Beaming System.
Orthofix's (OFIX) latest deal to boost Spine Fixation portfolio and strengthen hold in the high-potential artificial disc market buoys optimism.
Orthofix International N.V. , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that it has entered into a definitive agreement to acquire Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs.
Orthofix International N.V., , a global medical device company focused on musculoskeletal healing products and value-added services, today announced that John Sicard has been named to its Board of Directors.